BRENDA WALLACE: Open Payments
NPI 1104130426 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,693 in 129 payments from 26 companies in 2025. Trend: 2023 $732 · 2024 $1,710 · 2025 $2,693
Food & beverage: $2,593Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $303 |
| Astellas Pharma US Inc | 9 | $278 |
| Axsome Therapeutics, Inc. | 6 | $262 |
| GlaxoSmithKline, LLC. | 15 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $198 |
| AstraZeneca Pharmaceuticals LP | 7 | $171 |
| Lilly USA, LLC | 10 | $154 |
| Exact Sciences Corporation | 6 | $130 |
| Corcept Therapeutics | 4 | $127 |
| Abbott Laboratories | 5 | $113 |
Products named: Auvelity, CAPLYTA, Veozah, VRAYLAR, TRELEGY ELLIPTA, Korlym, FREESTYLE LIBRE 3, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
